Member Info for Investor81

They have sorted Uruguay and have funding for anza sorted too - through newmont.

Standard statement which is included by many companies. People trying to deramp again to get in even lower. Look at most prospectus and I'm sure you'll find disclaimers.

Ridiculous drop in SP following warrants being exercised!

No trades this morning?

Per my calculations unrestricted cash is approx £240m?

Is the 1p exercise price stated an error? If not thats a cracking deal for whoever has managed to get these options.

27-Dec-1916:39:2319.00150,000Sell*28.50kO 
27-Dec-1916:36:3619.001,050,000Sell*199.50kO 

Is this the final 1.2m?

Log will surely want a significant premium to today's price to justify not accepting the RRE offer for its debt.

Yet a few sells drive the price down?!

Can the company not get in touch with the FCA?

https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.nuformix.com/app/uploads/2019/09/NFX-Ebers-Strategic-Cannabinoid-Collaboration-Update-RNS.pdf&ved=2ahUKEwip7Jf4u8bmAhVSUMAKHVKXBBAQFjAAegQIAxAB&usg=AOvVaw0ltJOR3iMErX6_Jl4XlskN

See last paragraph.

'Global CBD product sales are estimated at £1.1bn in 2018 and forecast to reach £22bn by 20252, with GW Pharma's Epidiolex, a CBD-based pharmaceutical product, forecast to achieve annual sales of £1.7bn3. Through the agreement with Ebers Tech, Nuformix will benefit from adding its technology to a range of products into multiple markets versus taking a single product containing our technology into a single market.'

http://news.sky.com/story/cannabis-based-medicine-for-epilepsy-fast-tracked-by-nhs-11891892

- strong growth for the year, both operationally and financially.
- expect to report a significant increase in revenues.
- ... improved EBITDA.
- passenger numbers for our West Africa airport operations for the year are at record levels.
- new Ghana operations are performing well and have already produced several hundred thousand USD in revenues.
- Ghana contracts exchange is a formality given we are already appointed and operational.
- secured other business in the country.
- Saudi operations developing? Who is Sheikh Salman Bin Mohammed Bin Khalid Bin Hethlain and how influential is he?
- euro ops fully integrated within the group.
- various strategic alliances entered into.
- no further ferry obligations.
- sale of vessel generated $643k.
- anticipate 2020 will be another year of significant growth.
- Warrants exercised at 12.5p
 
https://www.wsg-corporate.com/news/new-contract-award-south-america-2/

1. Vanchem acquisition completed.
2. Mokopane mining licence granted.
3. Early settlement of Yellow Dragon earn out.
4. 375m Debt facility secured.
5. Supporting Redt-Avalon merger.
6. Enerox investment. Consortium led by BE on a debt free basis.
7. Working capital provided to other entities.
8. Planned maintenance programme completed ahead of schedule. 
9. Record monthly production in September.

And that's isn't everything.....

I thought they only had 6.88% - see RNS from end of November but this RNS states last position was 9.99%?

Thanks

Does anyone know why http://www.asianmetal.com/VanadiumPrice/Vanadium.html now show a 3 month date range for vanadium prices rather than the daily movements? Thanks

What an opportunity here!!

Company is generating barrels full of cash, increasing production and has strong cash reserves.

Add to this AA having a significant shareholding and looking to maximise shareholder value as he said in today's RNS 'This will add significant production and value to the Company, as we continue to deliver on our strategy; growing production and generating surplus cashflow that can be reinvested to maximise returns for shareholders'

'...as we continue to deliver on our strategy; growing production and generating surplus cashflow that can be reinvested to maximise returns for shareholders'

Garyn - BP have been there for a while and as part of the equity issue they took up their contractual rights for receiving warrants. The RNS never said they took any placing shares. Either people misread the RNS or ....